Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1CNS 1

Conditions

Lymphoma 3Sarcoma 1Recurrence 1Neuroblastoma 1Lymphoma, Non-Hodgkin 1Dendritic Cell Sarcoma, Interdigitating 1Central Nervous System Neoplasms 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 118Peripheral Blood Stem Cell Transplantation 67Filgrastim 60Etoposide 60Rituximab 54fludarabine phosphate 50Vincristine 46Radiotherapy 46Methotrexate 46Cytarabine 44Doxorubicin 40Cyclosporine 35Mycophenolic Acid 33Busulfan 33Prednisone 32Whole-Body Irradiation 31Tacrolimus 28Antilymphocyte Serum 28Melphalan 27Dexamethasone 26Methylprednisolone 22Leucovorin 19Carmustine 18Granulocyte Colony-Stimulating Factor 17Calcium Dobesilate 16Ifosfamide 15Psychiatric Rehabilitation 13Cord Blood Stem Cell Transplantation 13sargramostim 12merphos 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Burkitt Lymphoma × gallium nitrate × Clear all
NCT00002543 2013-07-18

Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
3 enrolled
CNSLymphoidSarcoma

Burkitt Lymphoma, Lymphoma, Neuroblastoma, Sarcoma, Central Nervous System Neoplasms, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡